Dr. Yan Chen, Senior Vice President, Antibody Research, X-BODY BioSciences, USA
09:10-09:40
Title: Technology and Process Evolutions in Vaccines Dr. Rene Labatut, Vice President, Global Manufacturing Technology, Sanofi Pasteur Inc., France
09:40-10:10
Title: Novel Antibodies for Respiratory and Autoimmune Diseases Dr. Zhengbin (Bing) Yao, Senior Vice President, MedImmune, USA
10:10-10:40
Title: From Treatment to Prevention: The Paradigm Going Forward Dr. Raymond E. Spier,President, The International Society for Vaccines, UK
10:40-11:10
Title: Antibody Mediated Cellular Immunotherapy for Cancer Dr. Yajun Guo, Professor, Second Military Medical University, China
11:10-11:40
Title: Higher Efficiencies - Fewer B Cells: An Optimized Protocol for Maximizing mAb Yields Dr. Robin E. Butler, Business Development Manager, BTX Harvard Apparatus, USA
Dr. Sreedhara Alavattam, Senior Group Leader, Genentech, Inc., USA
13:30-13:50
Title: Transgenic Mouse Platforms for Successful Human Therapeutic Antibody Discovery and Development Dr. Larry L. Green, CEO, Ablexis LLC., USA
13:50-14:10
Title: Autoxidation as a Possible Pathway in Monoclonal Antibody Degradation Dr. Sreedhara Alavattam, Senior Group Leader, Genentech, Inc., USA
14:10-14:30
Title: Luminex-based Immunoassay for the Selective Identification of Fragile-X Syndrome Utilizing Specific mAbs to FMRP Dr. Richard J. Kascsak, Head, New York State Instiute for Basic Research, USA
14:30-14:50
Title: Universal Therapeutic Monoclonal Antibodies against Influenza Viruses Dr. Stanley S. S. Hong, Senior Vice President, Business Development, Celltrion, Inc., South Korea
14:50-15:10
Title: Screening of Pluripotent Stem Cell Markers Using Antibodomics Methods Dr. Xiuli Song, Researcher, Hangzhou HuaAn Biotechnology Co.Ltd., China
15:10-15:30
Coffee Break
15:30-15:50
Title: Recent Innovations in Single-use Upstream MAb Production – The Practical Reality cGMP Dr. Barbara A. Paldus, CEO, Finesse Solutions, LLC, USA
15:50-16:10
Title: Theory and Measurement of Long Distance Interaction between Antibodies and Antigens Dr. Udo Riss,Managing Director, DRE-Dr. Riss Ellipsometerbau GmbH, Germany
16:10-16: 30
Title: Serum Profiling in Neuromuscular Dystrophies: Identifying Potential Protein Biomarkers Using Antibody Suspension Bead Arrays Dr. Cristina Al-Khalili Szigyarto, Scientific Coordinator, Royal Institute of Technology, Sweden
16:30-16:50
Title: Characterization of Novel Monoclonal Antibodies for Shiga Toxin 2 Produced by Pathogenic E. Coli and Their Use in Food Safety Dr. Xiaohua He, Research Molecular Biologist, United States Department of Agriculture, USA
16:50-17-10
Title: Impact of Antiphospholipid Antibodies on Mediated Interaction between Membranes – A Microvesiculation-suppression Effect Dr. Rado Janša, Head, Ljubljana University Medical Centre, Slovenia
Track 2: Innovative Tech Platforms for Antibodies
Section 2-1: Proteomics and Genomics Technology for Antibody
Dr. Igor Kozlov, Senior Director, Assay R&D, Prognosys Biosciences Inc., USA
13:30-13:55
Title: Microarray Technology for Proteomics Research Dr. Igor Kozlov,Senior Director, Prognosys Biosciences Inc., USA
13:55-14:20
Title: Rapid Identification of Monospecific Monoclonal Antibodies Using a Human Proteome Microarray Dr. Seth Blackshaw,Associate Professor, Johns Hopkins University School of Medicine, USA
14:20-14:45
Title: RiceAb--a Project for Generation Antibodies against Each Rice Proteins Dr. Guozhen Liu, Vice President, Beijing Protein Innovation Co., Ltd, China
14:45-15:10
Title: Antigen Binding Abilities of Antibody are Prescribed by Signal Sequence of Expression Vector in Genetic Immunization Dr. Kouju Kamata, Professor, The University of Jilin, The China-Japan Union Hospital, China
15:10-15:30
Coffee Break
Section 2-2: Nanotechnology, Microarray and Selection Technology for Antibody
Dr. Qiaoqiao Ruan, Principle Scientist, Abbott Laboratories, USA
08:30-08:50
Title: Supporting Immunoassay Design with Biophysical Tools Dr. Qiaoqiao Ruan, Principal Scientist, Abbott Laboratories, USA
08:50-09:10
Title: The VIVA|SCREEN Platform: A High Throughput Single B Lymphocytes Screening Technology for the Rapid Discovery and Production of Fully Human Antigen-specific Monoclonal Antibodies Dr. Philippe Guillot-Chêne, Senior Director, Vivalis, France
09:10-09:30
Title: Real-time Affinity Isotherm in a Single Injection for Rapid Affinity Analysis in High Throughput Screening Dr. John Quinn, Chief Scientific Officer, SensiQ Technologies Inc., USA
09:30-09:50
Title: High Throughput-High Content Phenotypic Drug Screening: Using the Power of Flow Cytometry Dr. Thomas Duensing, Vice President, Abgent Biotechnology (Suzhou) Co. Ltd., China
09:50-10:10
Title: Multiplex Protein Biomarker Analysis Solution - From ‘LightArray Biotech (ASIA) Research Center’ Dr. Yu Cheng, Project Manager, LightArray Biotech (ASIA) Rearch Center, China
10:10-10:30
Coffee Break
10:30-10:50
Title: Staphylococcal Surface Display for Generation of High-affinity Affibody Molecules and Antibody Fragments Dr. Filippa Fleetwood, Scientist, Royal Institute of Technology (KTH), Sweden
10:50-11:10
Title: Biochip Array Technology: A Multi-analytical Tool with Applications to Protein, DNA and Drug Analysis Dr. Wendy Zhang, Sales Executive, Randox Laboratories Limited, Shangai Representative Office, China
Dr. Christopher J. Mann, Global Lead Scientist, Biotherapeutics, Molecular Devices, UK
Co-Chair
Dr. Shuangping Shi, Group Leader, Merck Sharp & Dohme Corp, USA
08:30-08:50
Title: Advanced Screening Technologies for Expression of Monoclonal Antibodies Dr. Christopher J. Mann, Global Lead Scientist, Biotherapeutics, Molecular Devices, UK
08:50-09:10
Title: Production of Biopharmaceuticals in Chinese Hamster Ovary (CHO) Cells Dr. Shuangping Shi, Group Leader, Merck Sharp & Dohme Corp, USA
09:10-09:30
Title: Large Scale Transient Expression System with Yield Over 1 gram/L in Shaking Flask for Producing Recombinant Antibodies Dr. Changshou Gao, Principal Scientist, Department of Antibody Discovery & Protein Engineering, MedImmune LLC., USA
09:30-09:50
Title: Use of Homologous Recombination Based Gene Engineering for CHO Cell Line Optimization Dr. Joshua Kapp, Product & Business Development Manager, Bioproduction, Horizon Discovery Ltd., UK
Dr. Yan Chen, Senior Vice President, Antibody Research, X-BODY BioSciences, USA
10:30-10:50
Title: Generation and Affinity Maturation of Fully Human Soluble VH Domain Antibodies and IgGs Using dsDNA Display Dr. Yan Chen,Senior Vice President, Antibody Research, X-BODY BioSciences, USA
10:50-11:10
Title: MeMo®, A Transgenic Mouse for Human Bispecific Antibodies Dr. Ton Logtenberg, CEO, Merus Biopharmaceuticals, The Netherlands
11:10-11:30
Title: kλ-bodies: Fully Human Bispecific Antibodies Made Easy Dr. Nicolas Fischer,Head of Research, NovImmune SA, Switzerland
11:30-11:50
Title: BioLector High Throughput Fermentation System for Your Cell Screening and Optimization Dr. John Guan, Product Specialist, Bio Scientific Supplies, China
Track 3: Antibody Based Drug Discovery and Therapy-From Early to Late Stage
Section 3-1: Researches on Antibody Molecular Targets
Dr. Junjian Liu, Senior Scientist, Abbott Laboratories, USA
Co-Chair
Dr. Peter A. Ward, Stobbe Professor of Pathology, University of Michigan Medical School, USA
15:30-15:50
Title: Development of Novel Monovalent-Targeting Biotherapeutics Dr. Junjian Liu,Senior Scientist, Abbott Laboratories, USA
15:50-16:10
Title: Blockade of C5a in Sepsis: From Bench to Bedside Dr. Peter A. Ward, Stobbe Professor of Pathology, University of Michigan Medical School, USA
16:10-16:30
Title: Development of Cancer Vaccines by Engineering Antibody to Break Immune Tolerance Dr. T.-C. Wu, Professor, The Johns Hopkins Medical Institutions, USA
16:30-16:50
Title: Functional Inhibition of Transitory Poteins by Intrabody-mediated Retention in the Endoplasmatic Reticulum Dr. Thomas Böldicke, Scientist, Department of Gene Regulation and Differentiation, Helmholtz Centre for Infection Research, Germany
16:50-17:10
Title:Antibodies for Selection of Stem Cells: Heterogeneity and Prospective Isolation of Human Bone Marrow and Amnion-derived Mesenchymal Stem Cell (MSC) Subsets Dr. Hans-Jörg Bühring,Senior Scientist, University Clinic of Tübingen, Germany
Dr. Lionel Rostaing, Professor, Department of Nephrology, Dialysis and Organ Transplantation, CHU Toulouse Rangueil, France
11:10-11:30
Title: Induction Therapy in Organ Transplant Recipients except in Kidney Transplant Recipients Dr. Lionel Rostaing,Professor, Department of Nephrology, Dialysis and Organ Transplantation, CHU Toulouse Rangueil, France
11:30-11:50
Title: The T1DAL Study: Inducing Remission in Type 1 Diabetes with Alefacept Dr. Mark R. Rigby, Associate Professor, Indiana University, USA
11:50-12:10
Title: MAbs for Eyes Dr. Mei-Ling Tay-Kearney, Associate Professor, University of Western Australia, Australia
Dr. Rong-Hwa Lin, CEO & Chairman, AbGenomics International Inc., USA
13:30-13:55
Title: An Antibody Drug Conjugate against GI Cancers Dr. Rong-Hwa Lin,CEO & Chairman, AbGenomics International Inc., USA
13:55-14:20
Title: Targeted Therapies for Hematological Cancers: Are Antibodies the Best Choice of Drug Carrier? Dr. Michael A Firer, Professor, Ariel University Center, Israel
14:20-14:45
Title: Utilizing Antibody Based Treatment to Augment Cancer Therapy – Recent Advances Dr. Meng Xu Welliver, Assistant Professor, Ohio State University Comprehensive Cancer Center, USA
14:45-15:30
Coffee Break
Section 3-4: New Strategies and Trend for Antibody Based Drug Discovery
Dr. Titus Kretzschmar, CSO, Delenex Therapeutics AG, Switzerland
13:30-13:50
Keynote Speech: Title: Early CMC-activities in Therapeutic Antibody Development Dr. Ralf Ostendorp,Vice President, Protein Sciences, MorphoSys AG, Germany
13:50-14:10
Title: Antibodies for Local Therapy – Delivery Aspects Dr. Titus Kretzschmar, CSO, Delenex Therapeutics AG, Switzerland
14:10-14:30
Title: Implementing an Integrated Biomarker Strategy from Discovery to Translation: A Focus on Antibodies Dr. Christian Fritze, Senior Director, Discovery & Translational Services, Covance Inc., USA
14:30-14:50
Title: Early Phase Clinical Development of Antibody Dr. Dan Zhang, Chairman & CEO, Fountain Medical Development Ltd., China
14:50-15:10
Title: Anti-histone scFv Protects Endothelial Cells from the Toxicity of Circulating Histones Dr. Guozhen Wang, Consultant, Southeast University, China
15:10-15:30
Coffee Break
Section 3-5: Neutralizing Antibodies and Identification of Vaccine Targets
Dr. Wilfred Marissen, Project Director, Crucell Holland BV, The Netherlands
08:30-08:50
Title: Development of a Human Monoclonal Antibody Combination, CL184, for Use in Rabies Post-exposure Prophylaxis Dr. Wilfred Marissen, Project Director, Crucell Holland BV, The Netherlands
08:50-09:10
Title: True Human™ Antibodies: A Path to Safe and Effective Antibody Therapy Dr. Jay (Jian) Lin, Senior Scientist, Xbiotech USA Inc., USA
09:10-09:30
Title: Identification of Group A Streptococcus Vaccine Candidates Dr. Benfang Lei, Associate Professor, Montana State University, USA
Title: Highly Neutralizing Antibodies Specific for the Pre-fusion Form of the Human Respiratory Syncytial Virus Fusion Protein: A New Paradigm for Immune Intervention against This Virus Dr. José A. Melero, Scientist, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Spain
10:10-10:30
Coffee Break
Section 3-6: Therapeutic Mabs R & D for CNS Diseases
Dr. Xin-Fu Zhou, Professor, Flinders University, Australia
10:30-10:55
Title: Treatment of Alzheimer’s Disease with a Single Chain Antibody Fragment Dr. Xin-Fu Zhou, Professor, Flinders University, Australia
10:55-11:20
Title: TLR7/9 Agonists Enhance Therapeutic IFNβ-1a’s Effect on the Induction of Immunomodulatory Cytokine Secretion via Restoring an Insufficient IFNAR/TLR Signaling in Monocytes Derived from Patients with RR MS Dr. Yazhong Tao, Research Associate, Department of Neurology, University of North Carolina at Chapel Hill, USA
11:20-11:45
Title: Electrons Alleviate Bidirectional Moving of Antibodies in the Brain Following Diphtheria-tetanus Vaccination Dr. Katica Jovanova-Nesic, Professor & Director, Biomedical Center Institute of Virology, Vaccines and Sera-Torlak, Serbia
11:45-12:10
Title: AQP4 Antibody Positive Thai Cases: Clinical Features and Diagnostic Problems Dr. Sasitorn Siritho, Consultant Neurologist, Bamrungrad International Hospital, Thailand
Section 3-7: Therapeutic MAbs for Infection, Inflammatory and Autoimmune Diseases
Title:Passive Immunization for Effective Treatment of Viral Infections Dr. Robert Friesen, VP Preclinical & Clinical Research, R&D, Crucell, The Netherlands
14:20-14:45
Title: Conducting Drug Discovery at the Interface between Innate and Adaptive Immunity Dr. Carl K. Edwards, III,Professor, University of Colorado Denver, USA
14:45-15:10
Title: Systemic Lupus Erythematosus: After 50 Years No Longer "Lost in Translation" - The Pipeline of Therapeutic Antibodies is Here! Dr. C. Michael Neuwelt, Clinical Professor of Medicine, University of California, USA
15:10-15:30
Coffee Break
15:30-15:55
Title: Antimuscarinic Autoantibodies in Primary Sjogren Syndrome Patients Dr. Kyungpyo Park, Professor, Seoul National University, South Korea
15:55-16:20
Title: A Novel T Cell Apoptosis-inducing Antibody for T Cell-mediated Disease Dr. Shih-Yao Lin, Director, AbGenomics BV, Taiwan Branch, Taiwan
16:20-16:45
Title: Identification of B-cell Epitopes from the Structures of Allergen/Antibody Complexes Dr. Zora Markovic-Housley, Senior Researcher, Structural Biology, University of Basel, Switzerland
Dr. Liping Yu, Head, Clinical Immunology Laboratory, Barbara Davis Center for Childhood Diabetes, University of Colorado, USA
15:30-15:50
Title: Reconsidering the Concept of Autoimmunity: Possible Involvement of Environmental Factors in Development of Chronic Inflammatory Diseases Dr. Kuniaki Terato,Director & Founder, Chondrex Inc., USA
15:50-16:10
Title: Autoantibodies and Type 1 Diabetes Dr. Liping Yu, Head, Clinical Immunology Laboratory, Barbara Davis Center for Childhood Diabetes, University of Colorado, USA
16:10-16:30
Title: Development of Single Chain Antibody Fragments (scFvs) against Banana Streak MY Virus for Use in Diagnostics Dr. Andrew Geering, Senior Research Fellow, The University of Queensland, Australia
16:30-16:50
Title: Upregulation of Thyroid Transcription Factor-1 May Trigger Autoimmune Reaction in Hashimoto's Disease Dr. Huibin Huang, Professor, The Second Affiliated Hospital of Fujian Medical University, China
16:50-17:10
Title: Detection of Antibodies against Aquaporin-4 in Neuromyelitis Optica Spectrum and Tuberculous Meningitis, A Specificity Challenge Dr. Yanqing Feng, Associate Professor, The First Affiliated Hospital of SUN Yat-sen University, China
17:10-17:30
Title: Immunochemical Properties of Clinically Relevant Antibodies against beta2-glycoprotein I of Different Avidity Dr. Sasa Cucnik, Associate Professor, University Medical Centre, Slovenia
Track 5: Antibody Engineering and Production
Section 5-1: Generation and Purification of Antibody Fragments
Dr. Stéphane Birklé, Associate Professor, University of Nantes, France
08:30-08:50
Title: Next Generation Chromatography Platforms for Monoclonal Antibodies and Beyond Dr. Eva Heldin, Senior Scientist, GE Healthcare Life Sciences, Sweden
08:50-09:10
Title: Generation and Characterisation of a Mouse Monoclonal Antibody against the Neutral Glycolipid Gb3: A Potential Marker of Angiogenic Tumoral Endothelial Cells Dr. Stéphane Birklé, Associate Professor, University of Nantes, France
09:10-09:30
Title: Protein Adsorption and Impurity Removal Characteristics of Anion-exchange Hollow-fiber Membrane Adsorber with Grafted Chains Dr. Hironobu Shirataki, Chief Researcher, Asahi Kasei Medical Co., Ltd., Japan
09:30-09:50
Title:Application of New Modified Polyethersulfone Membrane (mPES) for Bio Separations Dr. Yingqing Huang, GeneralManager, Spectrum Labs (Shanghai) Co. Ltd., China
09:50-10:10
Title: Production of Recombinant Antibodies in Plants: Aspects, Potentials and Challenges Dr. Hamid Rajabi Memari, Assistant Professor, Shahid Chamran University of Ahvaz, Iran
Dr. Sebastien Chenuet, Business Development Manager, Cellectis bioresearch, France
Co-Chair
Dr. Tibor Anderlei, Head, Science and Business Development, Adolf Kühner AG, Switzerland
13:30-13:50
Title:Consistent Generation of Stable and Multigram-producing Clones Derived from CHO Cells in a 6-week Time Frame by the Mean of Hotspot Retargeting Dr. Sebastien Chenuet,Business Development Manager, Cellectis bioresearch, France
13:50-14:10
Title: Review: Shaken Bioreactors in the Field of Cell Cultivation Dr. Tibor Anderlei, Head, Science and Business Development, Adolf Kühner AG, Switzerland
14:10-14:30
Title: The Super CHO Cell Lines Used for Antibody Production Dr. Jiewei Wei, Manager, Australian Biobest Biotechnology Service, Australia
14:30-14:50
Title: The Application of Recombinant Human Serum Albumin in Antibody and Vaccine Manufacturing Dr. Daichang Yang, Professor, College of Life Sciences, Wuhan University, China
14:50-15:10
Title: Ambr: A New Tool for Automated Optimisation of Cell Culture for Biotherapeutics Dr. Ian Ransome, Global Business Director, TAP Biosystems, UK
Title: ClonePix 2: Second Generation Technology for Efficient Identification and Isolation of Mammalian Cell Clones for Monoclonal Antibody Production Dr. Qiang HuoLiang, Application Specialist, Molecular Devices, China
16:10-16:30
Title: Instrument Improvement for MAbs' Characterization and Production Dr. Cai Bin, Business Development Manager, Thermofisher Scientific, Singapore
16:30-16:50
Title: The EMABling® Platform: A Solution for the Production of Highly Active Antibodies Dr. Alexandre Fontayne, Head, Molecular Design, LFB Biotechnologies, France
16:50-17:10
Title: Opposition to Generic Biotech: Science or Politics? Dr. William F. Haddad, Chairman & CEO, Biogenerics, Inc., USA
Dr. Jen-Tsai Liu, Visiting Fellow, ElectroBioMedical Laboratory of Electrical Engineering, National Central University, Taiwan
10:30-10:55
Title: The Importance of Immuno-Sensor withHigh Anti-Fouling Ability Dr. Jen-Tsai Liu, Visiting Fellow, ElectroBioMedical Laboratory of Electrical Engineering, National Central University, Taiwan
10:55-11:20
Title: Autoantibody Detection in Human Prion Disease Dr. Koji Fujita, The University of Tokushima Graduate School, Japan
